Home > Press Releases > Point of Care Testing Market

Point of Care Testing Market Likely to Surpass USD 56.5 Billion by 2035

Report Code: HC-16150  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 297

Global Point of Care Testing Market Forecast 2035:

According to the report, the global point of care testing market is projected to expand from USD 26.4 billion in 2025 to USD 56.5 billion by 2035, registering a CAGR of 7.9%, the highest during the forecast period. The global point of care testing market is witnessing significant growth, driven by the increasing prevalence of chronic and infectious diseases and the rising demand for rapid, accurate, and convenient diagnostic solutions. Point of care testing enables immediate clinical decision-making, reduces the dependence on centralized laboratories, and supports timely interventions, which enhances patient outcomes across various healthcare settings.

Advancements in technology, including portable analyzers, biosensors, microfluidics, and AI-enabled devices, are further fueling market expansion. The trend towards home-based and decentralized healthcare, coupled with the growing adoption of telehealth and remote patient monitoring, has also increased the demand for over-the-counter and at-home point of care testing solutions.

Additionally, the rising focus on personalized and preventive healthcare is driving the development of specialized diagnostic tests that cater to individual patient needs. Supportive government initiatives, increasing healthcare awareness, and continuous innovation in test types are creating new growth opportunities. However, regulatory challenges and the need for quality standardization remain key considerations for market participants.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Point of Care Testing Market”

The rising trend of home-based and decentralized healthcare is significantly driving the growth of the point of care testing market. Consumers are increasingly seeking convenient, accurate, and rapid self-testing options that allow them to monitor health conditions from the comfort of their homes. This shift not only reduces the dependency on traditional laboratory testing but also supports remote patient monitoring, chronic disease management, and timely medical interventions, boosting demand for OTC and at-home point of care testing products.

The market faces significant restraints due to complex and regionally varying regulatory frameworks. These stringent approval processes can delay the launch of new point of care testing devices and assays, increase compliance costs, and require extensive clinical validation. Such regulatory challenges create barriers for both established players and new entrants, limiting the speed of innovation and wider adoption of point of care testing solutions across global healthcare settings.

The point of care testing market presents significant opportunities through the growing emphasis on personalized and preventive healthcare. Rising demand for individualized care and early disease detection is driving the development of more specialized point of care testing tests tailored to specific patient needs. These solutions enable timely interventions, improve patient outcomes, and support preventive health strategies, creating avenues for market expansion and innovation across clinical and home-based settings.

Expansion of Global Point of Care Testing Market

“Innovation that propel the global point of care testing market expansion”

  • The point of care testing market is experiencing rapid growth due to the increasing prevalence of chronic and infectious diseases, rising demand for quick and accurate diagnostic results, and the growing adoption of home-based and decentralized healthcare solutions.
  • Technological advancements, such as AI-enabled devices, portable analyzers, and connected digital platforms, are enhancing the efficiency and accessibility of point of care testing. Additionally, supportive government initiatives and public health programs are further driving market expansion globally.

Regional Analysis of Global Point of Care Testing Market

  • North America leads the point of care testing market due to the presence of well-established healthcare infrastructure, high adoption of advanced diagnostic technologies, and increasing awareness of rapid testing solutions. Supportive government initiatives, favorable reimbursement policies, and significant investments in research and development further drive the region’s growth. Additionally, the high prevalence of chronic and infectious diseases, coupled with the demand for decentralized and home-based healthcare solutions, contributes to North America maintaining a dominant position in the global point of care testing market.
  • The Asia Pacific point of care testing market is experiencing rapid growth due to increasing healthcare awareness, rising prevalence of chronic and infectious diseases, and expanding healthcare infrastructure across the region. Growing government initiatives, rising investments in diagnostic technologies, and improving access to decentralized and home-based testing solutions are further driving market adoption. Additionally, the large population base, rising disposable incomes, and increasing demand for quick and accurate diagnostic results are contributing to the accelerated growth of the point of care testing market in Asia Pacific.

Prominent players operating in the global point of care testing market are Abbott Laboratories, Accriva Diagnostics, Becton, Dickinson and Company (BD), bioMérieux, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics, Instrumentation Laboratory, Johnson & Johnson, Mesa Biotech, Nipro Corporation, Nova Biomedical, Polymedco, PTS Diagnostics, Quidel Corporation, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sight Diagnostics, Trinity Biotech, Other Key Players.

The global point of care testing market has been segmented as follows:

Global Point of Care Testing Market Analysis, By Product Type

  • Glucose Testing Kits
  • Infectious Disease Testing Kits
  • Cardiac Marker Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Blood Gas/Electrolyte Testing Kits
  • Cholesterol Testing Kits
  • Others

Global Point of Care Testing Market Analysis, By Technology Platform

  • Lateral Flow Assays
  • Immunoassays
  • Molecular Diagnostics
    • PCR-based
    • Isothermal Amplification
    • Microarray-based
    • Others
  • Clinical Chemistry
  • Hematology
  • Dipstick Technology
  • Microfluidics
  • Biosensors
    • Electrochemical Biosensors
    • Optical Biosensors
    • Piezoelectric Biosensors
    • Others
  • Other Technologies

Global Point of Care Testing Market Analysis, By Sample Type

  • Blood Samples
    • Whole Blood
    • Plasma
    • Serum
  • Urine Samples
  • Saliva Samples
  • Fecal Samples
  • Nasal/Throat Swabs
  • Other Body Fluids

Global Point of Care Testing Market Analysis, By Mode of Purchase

  • Prescription-based Devices
  • Over-the-Counter (OTC) Devices

Global Point of Care Testing Market Analysis, By Testing Complexity

  • CLIA-Waived Tests
  • Moderate Complexity Tests
  • High Complexity Tests

Global Point of Care Testing Market Analysis, By Test Result Time

  • Rapid Tests (<15 minutes)
  • Semi-Rapid Tests (15-30 minutes)
  • Standard Tests (>30 minutes)

Global Point of Care Testing Market Analysis, By Number of Parameters Tested

  • Single-Parameter Tests
  • Multi-Parameter Tests
    • 2-5 Parameters
    • 6-10 Parameters
    • More than 10 Parameters

Global Point of Care Testing Market Analysis, By Connectivity

  • Standalone Devices
  • Connected Devices
    • Bluetooth-enabled
    • WiFi-enabled
    • Cloud-connected
  • Integrated Laboratory Systems

Global Point of Care Testing Market Analysis, By End-use

  • Ambulatory Surgical Centers
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Hospitals
  • Military/Defense
  • Nursing Homes/Assisted Living
  • Pharmacies/Retail Clinics
  • Research Laboratories
  • Workplace/Occupational Health
  • Others

Global Point of Care Testing Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Point of Care Testing Market Outlook
      • 2.1.1. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of chronic and infectious diseases increasing demand for rapid, near-patient diagnostics
        • 4.1.1.2. Technological advancements enhancing accuracy, portability, and ease of use of point-of-care testing devices
        • 4.1.1.3. Growing shift toward decentralized healthcare, home testing, and remote patient monitoring
      • 4.1.2. Restraints
        • 4.1.2.1. Stringent regulatory requirements and standardization challenges for product approvals
        • 4.1.2.2. High costs of advanced point-of-care devices and limited reimbursement in some regions
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Ecosystem Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Point of Care Testing Market Demand
      • 4.7.1. Historical Market Size – Volume (Thousand Units) and Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Volume (Thousand Units) and Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Point of Care Testing Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Glucose Testing Kits
      • 6.2.2. Infectious Disease Testing Kits
      • 6.2.3. Cardiac Marker Testing Kits
      • 6.2.4. Pregnancy and Fertility Testing Kits
      • 6.2.5. Blood Gas/Electrolyte Testing Kits
      • 6.2.6. Cholesterol Testing Kits
      • 6.2.7. Others
  • 7. Global Point of Care Testing Market Analysis, by Technology Platform
    • 7.1. Key Segment Analysis
    • 7.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Technology Platform, 2021-2035
      • 7.2.1. Lateral Flow Assays
      • 7.2.2. Immunoassays
      • 7.2.3. Molecular Diagnostics
        • 7.2.3.1. PCR-based
        • 7.2.3.2. Isothermal Amplification
        • 7.2.3.3. Microarray-based
        • 7.2.3.4. Others
      • 7.2.4. Clinical Chemistry
      • 7.2.5. Hematology
      • 7.2.6. Dipstick Technology
      • 7.2.7. Microfluidics
      • 7.2.8. Biosensors
        • 7.2.8.1. Electrochemical Biosensors
        • 7.2.8.2. Optical Biosensors
        • 7.2.8.3. Piezoelectric Biosensors
        • 7.2.8.4. Others
      • 7.2.9. Other Technologies
  • 8. Global Point of Care Testing Market Analysis, by Sample Type
    • 8.1. Key Segment Analysis
    • 8.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Sample Type, 2021-2035
      • 8.2.1. Blood Samples
        • 8.2.1.1. Whole Blood
        • 8.2.1.2. Plasma
        • 8.2.1.3. Serum
      • 8.2.2. Urine Samples
      • 8.2.3. Saliva Samples
      • 8.2.4. Fecal Samples
      • 8.2.5. Nasal/Throat Swabs
      • 8.2.6. Other Body Fluids
  • 9. Global Point of Care Testing Market Analysis, by Mode of Purchase
    • 9.1. Key Segment Analysis
    • 9.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Implant Material, 2021-2035
      • 9.2.1. Prescription-based Devices
      • 9.2.2. Over-the-Counter (OTC) Devices
  • 10. Global Point of Care Testing Market Analysis, by Testing Complexity
    • 10.1. Key Segment Analysis
    • 10.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Testing Complexity, 2021-2035
      • 10.2.1. CLIA-Waived Tests
      • 10.2.2. Moderate Complexity Tests
      • 10.2.3. High Complexity Tests
  • 11. Global Point of Care Testing Market Analysis, by Test Result Time
    • 11.1. Key Segment Analysis
    • 11.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Test Result Time, 2021-2035
      • 11.2.1. Rapid Tests (<15 minutes)
      • 11.2.2. Semi-Rapid Tests (15-30 minutes)
      • 11.2.3. Standard Tests (>30 minutes)
  • 12. Global Point of Care Testing Market Analysis and Forecasts, by Number of Parameters Tested
    • 12.1. Key Findings
    • 12.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Number of Parameters Tested, 2021-2035
      • 12.2.1. Single-Parameter Tests
      • 12.2.2. Multi-Parameter Tests
        • 12.2.2.1. 2-5 Parameters
        • 12.2.2.2. 6-10 Parameters
        • 12.2.2.3. More than 10 Parameters
  • 13. Global Point of Care Testing Market Analysis and Forecasts, by Connectivity
    • 13.1. Key Findings
    • 13.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Connectivity, 2021-2035
      • 13.2.1. Standalone Devices
      • 13.2.2. Connected Devices
        • 13.2.2.1. Bluetooth-enabled
        • 13.2.2.2. WiFi-enabled
        • 13.2.2.3. Cloud-connected
      • 13.2.3. Integrated Laboratory Systems
  • 14. Global Point of Care Testing Market Analysis and Forecasts, by End-use
    • 14.1. Key Findings
    • 14.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by End-use, 2021-2035
      • 14.2.1. Ambulatory Surgical Centers
      • 14.2.2. Clinics
      • 14.2.3. Diagnostic Laboratories
      • 14.2.4. Home Care Settings
      • 14.2.5. Hospitals
      • 14.2.6. Military/Defense
      • 14.2.7. Nursing Homes/Assisted Living
      • 14.2.8. Pharmacies/Retail Clinics
      • 14.2.9. Research Laboratories
      • 14.2.10. Workplace/Occupational Health
      • 14.2.11. Others
  • 15. Global Point of Care Testing Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Point of Care Testing Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Product Type
      • 16.3.2. Technology Platform
      • 16.3.3. Sample Type
      • 16.3.4. Mode of Purchase
      • 16.3.5. Testing Complexity
      • 16.3.6. Test Result Time
      • 16.3.7. Connectivity
      • 16.3.8. End-Use
      • 16.3.9. Country
        • 16.3.9.1. USA
        • 16.3.9.2. Canada
        • 16.3.9.3. Mexico
    • 16.4. USA Point of Care Testing Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Technology Platform
      • 16.4.4. Sample Type
      • 16.4.5. Mode of Purchase
      • 16.4.6. Testing Complexity
      • 16.4.7. Test Result Time
      • 16.4.8. Connectivity
      • 16.4.9. End-Use
    • 16.5. Canada Point of Care Testing Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Technology Platform
      • 16.5.4. Sample Type
      • 16.5.5. Mode of Purchase
      • 16.5.6. Testing Complexity
      • 16.5.7. Test Result Time
      • 16.5.8. Connectivity
      • 16.5.9. End-Use
    • 16.6. Mexico Point of Care Testing Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Technology Platform
      • 16.6.4. Sample Type
      • 16.6.5. Mode of Purchase
      • 16.6.6. Testing Complexity
      • 16.6.7. Test Result Time
      • 16.6.8. Connectivity
      • 16.6.9. End-Use
  • 17. Europe Point of Care Testing Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Technology Platform
      • 17.3.3. Sample Type
      • 17.3.4. Mode of Purchase
      • 17.3.5. Testing Complexity
      • 17.3.6. Test Result Time
      • 17.3.7. Connectivity
      • 17.3.8. End-Use
      • 17.3.9. Country
        • 17.3.9.1. Germany
        • 17.3.9.2. United Kingdom
        • 17.3.9.3. France
        • 17.3.9.4. Italy
        • 17.3.9.5. Spain
        • 17.3.9.6. Netherlands
        • 17.3.9.7. Nordic Countries
        • 17.3.9.8. Poland
        • 17.3.9.9. Russia & CIS
        • 17.3.9.10. Rest of Europe
    • 17.4. Germany Point of Care Testing Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Technology Platform
      • 17.4.4. Sample Type
      • 17.4.5. Mode of Purchase
      • 17.4.6. Testing Complexity
      • 17.4.7. Test Result Time
      • 17.4.8. Connectivity
      • 17.4.9. End-Use
    • 17.5. United Kingdom Point of Care Testing Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Technology Platform
      • 17.5.4. Sample Type
      • 17.5.5. Mode of Purchase
      • 17.5.6. Testing Complexity
      • 17.5.7. Test Result Time
      • 17.5.8. Connectivity
      • 17.5.9. End-Use
    • 17.6. France Point of Care Testing Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Technology Platform
      • 17.6.4. Sample Type
      • 17.6.5. Mode of Purchase
      • 17.6.6. Testing Complexity
      • 17.6.7. Test Result Time
      • 17.6.8. Connectivity
      • 17.6.9. End-Use
    • 17.7. Italy Point of Care Testing Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Technology Platform
      • 17.7.4. Sample Type
      • 17.7.5. Mode of Purchase
      • 17.7.6. Testing Complexity
      • 17.7.7. Test Result Time
      • 17.7.8. Connectivity
      • 17.7.9. End-Use
    • 17.8. Spain Point of Care Testing Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Technology Platform
      • 17.8.4. Sample Type
      • 17.8.5. Mode of Purchase
      • 17.8.6. Testing Complexity
      • 17.8.7. Test Result Time
      • 17.8.8. Connectivity
      • 17.8.9. End-Use
    • 17.9. Netherlands Point of Care Testing Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Product Type
      • 17.9.3. Technology Platform
      • 17.9.4. Sample Type
      • 17.9.5. Mode of Purchase
      • 17.9.6. Testing Complexity
      • 17.9.7. Test Result Time
      • 17.9.8. Connectivity
      • 17.9.9. End-Use
    • 17.10. Nordic Countries Point of Care Testing Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Product Type
      • 17.10.3. Technology Platform
      • 17.10.4. Sample Type
      • 17.10.5. Mode of Purchase
      • 17.10.6. Testing Complexity
      • 17.10.7. Test Result Time
      • 17.10.8. Connectivity
      • 17.10.9. End-Use
    • 17.11. Poland Point of Care Testing Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Product Type
      • 17.11.3. Technology Platform
      • 17.11.4. Sample Type
      • 17.11.5. Mode of Purchase
      • 17.11.6. Testing Complexity
      • 17.11.7. Test Result Time
      • 17.11.8. Connectivity
      • 17.11.9. End-Use
    • 17.12. Russia & CIS Point of Care Testing Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Product Type
      • 17.12.3. Technology Platform
      • 17.12.4. Sample Type
      • 17.12.5. Mode of Purchase
      • 17.12.6. Testing Complexity
      • 17.12.7. Test Result Time
      • 17.12.8. Connectivity
      • 17.12.9. End-Use
    • 17.13. Rest of Europe Point of Care Testing Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Product Type
      • 17.13.3. Technology Platform
      • 17.13.4. Sample Type
      • 17.13.5. Mode of Purchase
      • 17.13.6. Testing Complexity
      • 17.13.7. Test Result Time
      • 17.13.8. Connectivity
      • 17.13.9. End-Use
  • 18. Asia Pacific Point of Care Testing Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Technology Platform
      • 18.3.3. Sample Type
      • 18.3.4. Mode of Purchase
      • 18.3.5. Testing Complexity
      • 18.3.6. Test Result Time
      • 18.3.7. Connectivity
      • 18.3.8. End-Use
      • 18.3.9. Country
        • 18.3.9.1. China
        • 18.3.9.2. India
        • 18.3.9.3. Japan
        • 18.3.9.4. South Korea
        • 18.3.9.5. Australia and New Zealand
        • 18.3.9.6. Indonesia
        • 18.3.9.7. Malaysia
        • 18.3.9.8. Thailand
        • 18.3.9.9. Vietnam
        • 18.3.9.10. Rest of Asia Pacific
    • 18.4. China Point of Care Testing Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Technology Platform
      • 18.4.4. Sample Type
      • 18.4.5. Mode of Purchase
      • 18.4.6. Testing Complexity
      • 18.4.7. Test Result Time
      • 18.4.8. Connectivity
      • 18.4.9. End-Use
    • 18.5. India Point of Care Testing Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Technology Platform
      • 18.5.4. Sample Type
      • 18.5.5. Mode of Purchase
      • 18.5.6. Testing Complexity
      • 18.5.7. Test Result Time
      • 18.5.8. Connectivity
      • 18.5.9. End-Use
    • 18.6. Japan Point of Care Testing Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Technology Platform
      • 18.6.4. Sample Type
      • 18.6.5. Mode of Purchase
      • 18.6.6. Testing Complexity
      • 18.6.7. Test Result Time
      • 18.6.8. Connectivity
      • 18.6.9. End-Use
    • 18.7. South Korea Point of Care Testing Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Product Type
      • 18.7.3. Technology Platform
      • 18.7.4. Sample Type
      • 18.7.5. Mode of Purchase
      • 18.7.6. Testing Complexity
      • 18.7.7. Test Result Time
      • 18.7.8. Connectivity
      • 18.7.9. End-Use
    • 18.8. Australia and New Zealand Point of Care Testing Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Product Type
      • 18.8.3. Technology Platform
      • 18.8.4. Sample Type
      • 18.8.5. Mode of Purchase
      • 18.8.6. Testing Complexity
      • 18.8.7. Test Result Time
      • 18.8.8. Connectivity
      • 18.8.9. End-Use
    • 18.9. Indonesia Point of Care Testing Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Product Type
      • 18.9.3. Technology Platform
      • 18.9.4. Sample Type
      • 18.9.5. Mode of Purchase
      • 18.9.6. Testing Complexity
      • 18.9.7. Test Result Time
      • 18.9.8. Connectivity
      • 18.9.9. End-Use
    • 18.10. Malaysia Point of Care Testing Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Product Type
      • 18.10.3. Technology Platform
      • 18.10.4. Sample Type
      • 18.10.5. Mode of Purchase
      • 18.10.6. Testing Complexity
      • 18.10.7. Test Result Time
      • 18.10.8. Connectivity
      • 18.10.9. End-Use
    • 18.11. Thailand Point of Care Testing Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Product Type
      • 18.11.3. Technology Platform
      • 18.11.4. Sample Type
      • 18.11.5. Mode of Purchase
      • 18.11.6. Testing Complexity
      • 18.11.7. Test Result Time
      • 18.11.8. Connectivity
      • 18.11.9. End-Use
    • 18.12. Vietnam Point of Care Testing Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Product Type
      • 18.12.3. Technology Platform
      • 18.12.4. Sample Type
      • 18.12.5. Mode of Purchase
      • 18.12.6. Testing Complexity
      • 18.12.7. Test Result Time
      • 18.12.8. Connectivity
      • 18.12.9. End-Use
    • 18.13. Rest of Asia Pacific Point of Care Testing Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Product Type
      • 18.13.3. Technology Platform
      • 18.13.4. Sample Type
      • 18.13.5. Mode of Purchase
      • 18.13.6. Testing Complexity
      • 18.13.7. Test Result Time
      • 18.13.8. Connectivity
      • 18.13.9. End-Use
  • 19. Middle East Point of Care Testing Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Product Type
      • 19.3.2. Technology Platform
      • 19.3.3. Sample Type
      • 19.3.4. Mode of Purchase
      • 19.3.5. Testing Complexity
      • 19.3.6. Test Result Time
      • 19.3.7. Connectivity
      • 19.3.8. End-Use
      • 19.3.9. Country
        • 19.3.9.1. Turkey
        • 19.3.9.2. UAE
        • 19.3.9.3. Saudi Arabia
        • 19.3.9.4. Israel
        • 19.3.9.5. Rest of Middle East
    • 19.4. Turkey Point of Care Testing Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Product Type
      • 19.4.3. Technology Platform
      • 19.4.4. Sample Type
      • 19.4.5. Mode of Purchase
      • 19.4.6. Testing Complexity
      • 19.4.7. Test Result Time
      • 19.4.8. Connectivity
      • 19.4.9. End-Use
    • 19.5. UAE Point of Care Testing Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Product Type
      • 19.5.3. Technology Platform
      • 19.5.4. Sample Type
      • 19.5.5. Mode of Purchase
      • 19.5.6. Testing Complexity
      • 19.5.7. Test Result Time
      • 19.5.8. Connectivity
      • 19.5.9. End-Use
    • 19.6. Saudi Arabia Point of Care Testing Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Product Type
      • 19.6.3. Technology Platform
      • 19.6.4. Sample Type
      • 19.6.5. Mode of Purchase
      • 19.6.6. Testing Complexity
      • 19.6.7. Test Result Time
      • 19.6.8. Connectivity
      • 19.6.9. End-Use
    • 19.7. Israel Point of Care Testing Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Product Type
      • 19.7.3. Technology Platform
      • 19.7.4. Sample Type
      • 19.7.5. Mode of Purchase
      • 19.7.6. Testing Complexity
      • 19.7.7. Test Result Time
      • 19.7.8. Connectivity
      • 19.7.9. End-Use Age Group
      • 19.7.10. End-Use
    • 19.8. Rest of Middle East Point of Care Testing Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Product Type
      • 19.8.3. Technology Platform
      • 19.8.4. Sample Type
      • 19.8.5. Mode of Purchase
      • 19.8.6. Testing Complexity
      • 19.8.7. Test Result Time
      • 19.8.8. Connectivity
      • 19.8.9. End-Use
  • 20. Africa Point of Care Testing Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Product Type
      • 20.3.2. Technology Platform
      • 20.3.3. Sample Type
      • 20.3.4. Mode of Purchase
      • 20.3.5. Testing Complexity
      • 20.3.6. Test Result Time
      • 20.3.7. Connectivity
      • 20.3.8. End-Use
      • 20.3.9. Country
        • 20.3.9.1. South Africa
        • 20.3.9.2. Egypt
        • 20.3.9.3. Nigeria
        • 20.3.9.4. Algeria
        • 20.3.9.5. Rest of Africa
    • 20.4. South Africa Point of Care Testing Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Product Type
      • 20.4.3. Technology Platform
      • 20.4.4. Sample Type
      • 20.4.5. Mode of Purchase
      • 20.4.6. Testing Complexity
      • 20.4.7. Test Result Time
      • 20.4.8. Connectivity
      • 20.4.9. End-Use
    • 20.5. Egypt Point of Care Testing Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Product Type
      • 20.5.3. Technology Platform
      • 20.5.4. Sample Type
      • 20.5.5. Mode of Purchase
      • 20.5.6. Testing Complexity
      • 20.5.7. Test Result Time
      • 20.5.8. Connectivity
      • 20.5.9. End-Use
    • 20.6. Nigeria Point of Care Testing Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Product Type
      • 20.6.3. Technology Platform
      • 20.6.4. Sample Type
      • 20.6.5. Mode of Purchase
      • 20.6.6. Testing Complexity
      • 20.6.7. Test Result Time
      • 20.6.8. Connectivity
      • 20.6.9. End-Use
    • 20.7. Algeria Point of Care Testing Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Product Type
      • 20.7.3. Technology Platform
      • 20.7.4. Sample Type
      • 20.7.5. Mode of Purchase
      • 20.7.6. Testing Complexity
      • 20.7.7. Test Result Time
      • 20.7.8. Connectivity
      • 20.7.9. End-Use
    • 20.8. Rest of Africa Point of Care Testing Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Product Type
      • 20.8.3. Technology Platform
      • 20.8.4. Sample Type
      • 20.8.5. Mode of Purchase
      • 20.8.6. Testing Complexity
      • 20.8.7. Test Result Time
      • 20.8.8. Connectivity
      • 20.8.9. End-Use
  • 21. South America Point of Care Testing Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Point of Care Testing Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Product Type
      • 21.3.2. Technology Platform
      • 21.3.3. Sample Type
      • 21.3.4. Mode of Purchase
      • 21.3.5. Testing Complexity
      • 21.3.6. Test Result Time
      • 21.3.7. Connectivity
      • 21.3.8. End-Use
      • 21.3.9. Country
        • 21.3.9.1. Brazil
        • 21.3.9.2. Argentina
        • 21.3.9.3. Rest of South America
    • 21.4. Brazil Point of Care Testing Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Product Type
      • 21.4.3. Technology Platform
      • 21.4.4. Sample Type
      • 21.4.5. Mode of Purchase
      • 21.4.6. Testing Complexity
      • 21.4.7. Test Result Time
      • 21.4.8. Connectivity
      • 21.4.9. End-Use
    • 21.5. Argentina Point of Care Testing Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Product Type
      • 21.5.3. Technology Platform
      • 21.5.4. Sample Type
      • 21.5.5. Mode of Purchase
      • 21.5.6. Testing Complexity
      • 21.5.7. Test Result Time
      • 21.5.8. Connectivity
      • 21.5.9. End-Use
    • 21.6. Rest of South America Point of Care Testing Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Product Type
      • 21.6.3. Technology Platform
      • 21.6.4. Sample Type
      • 21.6.5. Mode of Purchase
      • 21.6.6. Testing Complexity
      • 21.6.7. Test Result Time
      • 21.6.8. Connectivity
      • 21.6.9. End-Use
  • 22. Key Players/ Company Profile
    • 22.1. Abbott Laboratories
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. Accriva Diagnostics
    • 22.3. Becton, Dickinson and Company (BD)
    • 22.4. bioMérieux
    • 22.5. Chembio Diagnostics
    • 22.6. Danaher Corporation
    • 22.7. EKF Diagnostics
    • 22.8. Instrumentation Laboratory
    • 22.9. Johnson & Johnson
    • 22.10. Mesa Biotech
    • 22.11. Nipro Corporation
    • 22.12. Nova Biomedical
    • 22.13. Polymedco
    • 22.14. PTS Diagnostics
    • 22.15. Quidel Corporation
    • 22.16. Roche Diagnostics
    • 22.17. Sekisui Diagnostics
    • 22.18. Siemens Healthineers
    • 22.19. Sight Diagnostics
    • 22.20. Trinity Biotech
    • 22.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation